104 related articles for article (PubMed ID: 8631163)
1. The pharmacokinetics and UK usage of heparin in vascular intervention.
Zaman SM; de Vroos Meiring P; Gandhi MR; Gaines PA
Clin Radiol; 1996 Feb; 51(2):113-6. PubMed ID: 8631163
[TBL] [Abstract][Full Text] [Related]
2. Current trends in heparin use during arterial vascular interventional radiology.
Durran AC; Watts C
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1308-14. PubMed ID: 22245914
[TBL] [Abstract][Full Text] [Related]
3. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
[TBL] [Abstract][Full Text] [Related]
4. Current usage of contrast agents, anticoagulant and antiplatelet drugs in angiography and angioplasty in the UK.
Jackson DM; Dawson P
Clin Radiol; 1995 Oct; 50(10):699-704. PubMed ID: 7586963
[TBL] [Abstract][Full Text] [Related]
5. Periprocedural prophylactic antithrombotic strategies in interventional radiology: current practice in the Netherlands and comparison with the United kingdom.
Wiersema AM; Vos JA; Bruijninckx CMA; van Delden OM; Reijnen MMPJ; Vahl A; Zeebregts CJ; Moll FL
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1477-1492. PubMed ID: 23404518
[TBL] [Abstract][Full Text] [Related]
6. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
Topol EJ; Bonan R; Jewitt D; Sigwart U; Kakkar VV; Rothman M; de Bono D; Ferguson J; Willerson JT; Strony J
Circulation; 1993 May; 87(5):1622-9. PubMed ID: 8491018
[TBL] [Abstract][Full Text] [Related]
7. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
8. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
Lord H; Jean N; Dumont M; Kassis J; Leblanc M
Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
[TBL] [Abstract][Full Text] [Related]
9. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinski EJ; Roubin GS
J Am Coll Cardiol; 1993 Nov; 22(5):1273-9. PubMed ID: 8227779
[TBL] [Abstract][Full Text] [Related]
10. [Heparins].
Marbet GA
Ther Umsch; 2003 Jan; 60(1):10-3. PubMed ID: 12638471
[TBL] [Abstract][Full Text] [Related]
11. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
[TBL] [Abstract][Full Text] [Related]
12. Heparin in angiography: current patterns of use.
Miller DL
Radiology; 1989 Sep; 172(3 Pt 2):1007-11. PubMed ID: 2672098
[TBL] [Abstract][Full Text] [Related]
13. [Femoral artery hemostasis after coronary angioplasty with moderate dose of heparin].
Aubry P; Benamer H; Deye N; Coco M; Gaultier C; Boudvillain O; Feldman LJ; Himbert D; Steg PG; Juliard JM
Arch Mal Coeur Vaiss; 2003 Feb; 96(2):79-84. PubMed ID: 14626729
[TBL] [Abstract][Full Text] [Related]
14. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
[TBL] [Abstract][Full Text] [Related]
15. Effect of heparin on activated partial thromboplastin time in patients undergoing gynecologic or obstetric surgery.
Watanabe T; Minakami H; Sakata Y; Obara H; Wada T; Onagawa T; Sato I
Gynecol Obstet Invest; 2001; 51(3):178-83. PubMed ID: 11306905
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
[TBL] [Abstract][Full Text] [Related]
17. [Current patterns of the use of heparin in angiography].
Miller DL
J Radiol; 1990 Mar; 71(3):151-7. PubMed ID: 2191118
[TBL] [Abstract][Full Text] [Related]
18. Is activated clotting time necessary to guide sheath removal in heparinised patients undergoing endovascular intervention for peripheral vascular disease?
Tan MC; Duff K; Roberts L; Ramachandran V
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):23-26. PubMed ID: 31823475
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of optimal dosage of heparin in hemodialysis patients by thromboelastograph].
Yang ST; Wu H; Gao XY; Hu J; Xiao YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):625-9. PubMed ID: 23939176
[TBL] [Abstract][Full Text] [Related]
20. The monitoring of heparin administration by screening tests in experimental dogs.
Mischke R; Jacobs C
Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
